First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent.
Tuberculin is still the only available skin test reagent for the diagnosis of mycobacterial infection. The product has a remarkable sensitivity, but poor specificity. Previous studies, including two human phase I clinical trials, have indicated that rdESAT-6 has a potential as an improved skin test...
Main Authors: | Winnie Bergstedt, Pernille N Tingskov, Birgit Thierry-Carstensen, Søren T Hoff, Henrik Aggerbeck, Vibeke O Thomsen, Peter Andersen, Aase B Andersen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-06-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2892483?pdf=render |
Similar Items
-
ESAT-6/CFP10 skin test predicts disease in M. tuberculosis-infected guinea pigs.
by: Karin Weldingh, et al.
Published: (2008-01-01) -
Macrophage Immune Response Suppression by Recombinant Mycobacterium tuberculosis Antigens, the ESAT-6, CFP-10, and ESAT-6/CFP-10 Fusion Proteins
by: Atefeh Seghatoleslam, et al.
Published: (2016-07-01) -
IMMUNOLOGICAL TESTS USING MYCOBACTERIUM TUBERCULOSISSPECIFIC PROTEINS ESAT-6 AND CFP-10
by: Л. В. Слогоцкая
Published: (2014-01-01) -
Cloning, expression and purification of Mycobacterium tuberculosis ESAT-6 and CFP-10 antigens
by: Shima Mahmoudi, et al.
Published: (2013-12-01) -
ESAT-6 and CFP-10 antigens as a biotechnology molecule substrate. Applications in medicine
by: Dmitry A. Kudlai, et al.
Published: (2022-07-01)